Noveris Health Sciences, Inc. is a biotechnology company, which engages in the development of medications and therapies to address mental health disorders such as nicotine addiction and post-traumatic stress disorder (PTSD). The company was founded by Parente Carman, Damon Michaels, and Robert Roscow on September 27, 2013 and is headquartered in Vancouver, Canada.
Sector:
Health Technology
Industry:
Pharmaceuticals Other
Employees:
N/A
Frequently Asked Questions
What is Market Cap of Noveris Health Sciences Inc. - Ordinary Shares New?
Market cap, also known as market capitalization, is the total market value of a company. It's calculated by multiplying the current market price by the total number of shares outstanding. Noveris Health Sciences Inc. - Ordinary Shares New market cap is $6.73M.
What is the 52-week high for Noveris Health Sciences Inc. - Ordinary Shares New?
52 week high is the highest price of a stock in the past 52 weeks, or one year. Noveris Health Sciences Inc. - Ordinary Shares New 52 week high is $3.00 as of September 04, 2026.
What is the 52-week low for Noveris Health Sciences Inc. - Ordinary Shares New?
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Noveris Health Sciences Inc. - Ordinary Shares New 52 week low is $0.11 as of September 04, 2026.
What is Noveris Health Sciences Inc. - Ordinary Shares New stock price today?
Noveris Health Sciences Inc. - Ordinary Shares New stock price today is $0.115.
What was Noveris Health Sciences Inc. - Ordinary Shares New stock price yesterday?
Noveris Health Sciences Inc. - Ordinary Shares New stock price yesterday was $0.115.
What is the PE ratio of Noveris Health Sciences Inc. - Ordinary Shares New?
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It's calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company's Market Cap by the Net Profit. Noveris Health Sciences Inc. - Ordinary Shares New's P/E ratio is 0.05.
What is the Price-to-Book ratio of Noveris Health Sciences Inc. - Ordinary Shares New?
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It's calculated by dividing a company's market capitalization by its book value. Noveris Health Sciences Inc. - Ordinary Shares New P/B ratio is -3.0176.
What is the 50-day moving average of Noveris Health Sciences Inc. - Ordinary Shares New?
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It's calculated by averaging the closing stock price over the previous 50 trading days. Noveris Health Sciences Inc. - Ordinary Shares New 50-day moving average is $0.8887.
